Latest news, press releases, and SEC filings for Genmab A/S (GNMSF) https://caymanjournal.com/stock/GNMSF en-us Copyright 2026, Cayman Journal editorial@caymanjournal.com (Editorial Team) webmaster@caymanjournal.com (Web Master) Tue, 28 Apr 2026 00:04:31 GMT 60 https://caymanjournal.com/logo.png https://caymanjournal.com 144 144 # 🧾 What This Document Is This is a standard regulatory filing, called a 6-K, from the biotech company Genmab. Its sole purpose is to publicly disclose stock transactions made by its top executives. Think of it as a required transparency report so investors know what the company's leaders are doin https://caymanjournal.com/stock/GNMSF/sec-filing/0001434265-26-000057 https://caymanjournal.com/stock/GNMSF/sec-filing/0001434265-26-000057 Wed, 01 Apr 2026 00:00:00 GMT SEC Filing # 🧾 What This Document Is This is a **6-K filing**, which is a report international companies like Genmab (based in Denmark) submit to the U.S. SEC to announce major events. This specific event is a **"Major Shareholder Announcement."** It's a formal notification required by Danish law when an inve https://caymanjournal.com/stock/GNMSF/sec-filing/0001434265-26-000054 https://caymanjournal.com/stock/GNMSF/sec-filing/0001434265-26-000054 Wed, 01 Apr 2026 00:00:00 GMT SEC Filing # 🧾 What This Document Is This is a **6-K form**, which is a current report filed with the SEC by foreign companies (like Danish Genmab) to share important events with U.S. investors. This specific filing is a "Major Shareholder Announcement." It's like a mandatory public notification saying, "Hey, https://caymanjournal.com/stock/GNMSF/sec-filing/0001434265-26-000052 https://caymanjournal.com/stock/GNMSF/sec-filing/0001434265-26-000052 Mon, 30 Mar 2026 00:00:00 GMT SEC Filing